IL6 and COVID-19: A meta-analysis of 6320 patients reported that patients having elevated levels of IL-6, IL-10, ESR, and PCT were more prone to develop severe-stage COVID-19, while high levels of D-dimer, PT, and rapidly lowered levels of fibrinogen at the latter stages of hospitalization were specifically observed in non-survivors [16,26].